ロード中...
Budesonide–formoterol (inhalation powder) in the treatment of COPD
The budesonide–formoterol dry powder inhaler (Symbicort(®) Turbuhaler(®) 160/4.5–640/18 μg/day) contains the long-acting β(2)-adrenoreceptor agonist formoterol and the inhaled corticosteroid budesonide. Two large, 12-month trials examined the effect of budesonide–formoterol 160/4.5 μg twice daily in...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2006
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2706613/ https://ncbi.nlm.nih.gov/pubmed/18046888 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|